Press releases
April 2024

A common goal, to improve the lives of patients

Zambon and Vectans Pharma laboratories have entered into a partnership to ensure the marketing of Virpax®, Lauriad® Aciclovir 50mg, in France.

Read the press release
March 2023

Exclusive agreement with the Menarini group and Berlin Chemie for Sitavig®

Read the press release
September 2022

Exclusive agreement with Berlin Chemie for Sitavig® in Eastern Europe and the CIS region

Read the press release
August 2022

Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Read the press release
March 2022

Nomination of François Boutignon as Chief Innovation and Technology Officer

Read the press release
January 2021

China approves commercialization for Oravig®

Read the press release
February 2020

Exclusive licensing agreement with m8 Pharmaceuticals

Read the press release
Image Medias
230 Bureaux de la colline
92213 Saint-Cloud
France

contact@vectans.com

logo-footer-10

  FOLLOW US

Copyright © VECTANS PHARMA

Legal notices and privacy policy